Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
USC Clinical Rheumatology Update
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
80 y/o Male With Immune Complex-Mediated Tubulointerstitial Nephritis, Seronegative Inflammatory Arthritis, and Severe Polyarticular Joint Pain: Why It's Important to Question Seronegative Inflammatory Arthritis? How Important Is Arthrocentesis?
FEATURING
Lauren Mathias
- 316 views
- November 26, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Calcium Crystal Deposition in Gout: What Is the Impact of CCP, and BCP Crystals in Acute CCP Crystal Arthritis? What Are the Current Therapies for CPPD?
FEATURING
Sky Wang
- 733 views
- November 24, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Update on Sjogren's Syndrome: How to Manage Sicca, and Extraglandular Symptoms Through Topical NSAIDs, Corticosteroids, and Immunosuppressants?
FEATURING
Jenny Jun
- 710 views
- November 24, 2020
- 12
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Sjogren's Syndrome Diagnosis: What Are the Testing Methodologies, and Diagnosis Criteria? What Is the Importance of Additional Criteria Not Outlined by ACR or EULAR?
FEATURING
Jenny Jun
- 321 views
- November 24, 2020
- 3
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Ocular Toxicity of Rheumatologic Drugs: What Is the Role and Effects of Traditional DMARDs, Biologic DMARDs, Chloroquine and Hydroxychloroquine on Ocular Health?
FEATURING
Linda Lam
- 158 views
- November 24, 2020
- 2
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Update on SLE Classification: What Are New SLICC, EULAR, and ACR Items and Definitions? What Is the Goal of Specificity, and the Importance of Immunology?
FEATURING
Stavros Savvas
- 187 views
- November 24, 2020
- 2
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Emerging Therapeutics in SLE: What Is the Impact and Efficacy of Anifrolumab, Ustekinumab, Baricitinib, and the New JAK Inhibitors?
FEATURING
Stavros Savvas
- 370 views
- November 24, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
COVID-19 in RMD Patients: What Are the Risk Factors for Severe COVID-19 Outcomes? Are Patients With APL Antibodies at Higher Risk for Thrombotic Events?
FEATURING
Leanna Wise
- 670 views
- November 24, 2020
- 4
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Treatment of RMD COVID-19 Patients: Are Anti-Rheumatic Drugs Proving Efficacy in Recovery? What Are the Current ACR Recommendations for COVID-19 Positive and Negative Patients?
FEATURING
Leanna Wise
- 372 views
- November 24, 2020
- 3
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Skin Manifestations of COVID-19: What Are the Most Common Patterns of Injury and How to Treat Them? Are Skin Manifestations of COVID-19 Heterogeneous? Can They Be Life-Threatening?
FEATURING
Binh Ngo
- 388 views
- November 11, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Use of Cannibis in Rheumatology: What Are the Effects and Efficacy for Use in Fibromyalgia, RA, SLE, AS, FMF, Crohn's, Systemic Sclerosis, and Osteoarthritis?
FEATURING
Samy Metyas
- 4,152 views
- November 11, 2020
- 24
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Medical Marijuana and CBD in Rheumatology: How Effective Is for Chronic Pain and Inflammation? What Are the Cannabis Pharmacological (CNS) Effects, and FDA Approved Medication?
FEATURING
Samy Metyas
- 921 views
- November 11, 2020
- 8
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
New Treatment Approaches for Psoriasis: What Are the AAD Management Recommendations? What Is the Efficacy of Topical Agents, Phototherapy, and Systemic Agents?
FEATURING
Binh Ngo
- 681 views
- November 11, 2020
- 6
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
axSpA Treatment Update: What Is the Response Rate, Proper Use and Efficacy of Specific NSAIDS, csDMARDs, TNF Inhibitors and JAK Inhibitors?
FEATURING
Daniel Arkfeld
- 1,744 views
- November 11, 2020
- 6
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
Imaging in RA and axSpA: What Can Be Seen in Plain Imaging, Ultrasounds, MRI and Retroadvanced Imaging? What Does the Future Hold for OA Imaging, PET/CT Scans and AI for Early Detection of Arthritic Conditions?
FEATURING
Stratos Christianakis
- 628 views
- November 11, 2020
- 5
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
RA and Biologic Therapies Update: Where Do Products Fit on the RA Spectrum of Treatment? What Are Specifics on TNF Inhibitors, Il-1, Il-6 Receptor Blockers and CD20 Antigens on Lymphocytes?
FEATURING
Glenn Ehresmann
- 491 views
- November 11, 2020
- 4
USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders
DMARDS Biologic in RA: What Are Safety Issues and Concerns? What Are the Malignancy, and Immune Disease Risks Induced by Biologics?
FEATURING
Glenn Ehresmann
- 300 views
- November 11, 2020
- 3
